Who invested in Vergent Bioscience?
Vergent Bioscience's investors include Colle Capital Partners and Spring Mountain Capital.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$30Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $8.7M sold, first sale May 2018
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Vergent Bioscience's investors include Colle Capital Partners and Spring Mountain Capital.
Vergent Bioscience has raised $30M across 2 rounds since 2018.
Vergent Bioscience's most recent round was a Series B of $22M in Oct 2022.
Its most recent round, $22M in Oct 2022, is also its largest on record.
Vergent Bioscience's first round on record, in Jun 2018, was backed by Spring Mountain Capital.
Vergent Bioscience's latest named round is a Series B, in Oct 2022.
Vergent Bioscience is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.